Article Text

PDF

Cardiovascular clinical pharmaceutical research
Study of Serum YKL-40 Level and Impaired glucose tolerance combined with cardiovascular diseases risk
  1. Ren Jie,
  2. Qin Minzhao
  1. Beijing Tongren Hospital, Beijing, China

Abstract

Background and Objective Diabetes has become a common healthy problem in the world, which is an autoimmune disease mediated by inflammatory cytokine. Inflammation plays an important role in the pathogenesis of diabetes and macrovascular complications. Chitinase-3-like protein-1 (YKL-40) is a new inflammatory factor, which can influence the level of other inflammatory markers and related to the development of cardiovascular diseases. This study aims to investigate the level of YKL-40 in patients with diabetes and impaired glucose tolerance. Correlation between YKL-40 and blood glucose, lipids, high sensitivity C-reactive protein, IMT was compared.

Subjects and methods 135 patients (Beijing Tong Ren Hospital)were enrolled (male, 96, female, 39; ages 65±13) They were divided into three groups: DM patients (n=77), IGT patients (n=38) and controls (n=20). The level of serum YKL-40 was measured by ELLISA. Lipids, HbA1C, plasma glucose and serum high-sensitivity C-reactive protein (hs-CRP) were detected by routine methods. Date was performed on High-resolution B-model ultrasound. Data was analysed using SPSS16.

Results (1) Serum YKL-40 levels in DM group was higher than that in control group (p=0.02). It was higher in IGT group than that in control group, but without statistically significance (p=0.08). It was of no significant difference between DM and IGT group (p=0.06). (2) IMT was different among three groups (p<0.05). (3) The serum YKL-40 level was associated with DM (B=−0.08, p=0.007, OR 0.992). After adjusting age, gender, creatinine and the risk factors of CAD, diabetic family history, hypertension, smoking and hs-CRP, it was still associated with DM (B=−0.009, p=0.01, OR 0.991). (4) The serum YKL-40 level was associated with DM combined with atherosclerosis (B=−277, p=0.026, OR 1.319). (5) There was a notable correlation between the serum YKL-40 levels and IGT with cardiovascular risks (X2=6.96, p=0.016).

Conclusions (1) The level of serum YKL-40 was increased in patients with DM and IGT. (2) The level of serum YKL-40 was associated with diabetes. (3) The level of serum YKL-40 may be used as an independent predicted factor for cardiovascular risk in IGT.

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.